Cargando…

114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination

BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnaout, Sami, Ellison, Richard T, Greenough, Thomas C, Wedig, Azalea, Mitchell, Michael J, John, Lauren St, Stock, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644678/
http://dx.doi.org/10.1093/ofid/ofab466.114
_version_ 1784610141065183232
author Arnaout, Sami
Ellison, Richard T
Greenough, Thomas C
Wedig, Azalea
Mitchell, Michael J
John, Lauren St
Stock, Shannon
author_facet Arnaout, Sami
Ellison, Richard T
Greenough, Thomas C
Wedig, Azalea
Mitchell, Michael J
John, Lauren St
Stock, Shannon
author_sort Arnaout, Sami
collection PubMed
description BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bottle. We have assessed the effectiveness of one blood diversion device in a prospective trial performed at the two separate emergency departments (EDs) of a three-campus Academic Medical Center. METHODS: A multi-phase prospective crossover trial was performed with the blood diversion device initially in use at one ED (Memorial) and standard equipment at the other ED (University) for 10 weeks. After a washout phase, a second 10-week study phase used the blood diversion device in the other ED (University) and standard equipment at the first ED (Memorial). Contaminants were identified by the clinical microbiology lab using standard criteria, and further defined by independent retrospective review by 3 infectious disease physicians prior to statistical analysis. An intention-to-treat analysis was performed, and Chi-square tests were used to compare contaminant rates among samples obtained using the blood diversion device versus standard equipment. RESULTS: 5,675 blood samples were obtained with 5,661 samples analyzed after 14 were deemed inconclusive by the ID physician review. There were 1,719 samples obtained at Memorial ED and 3,942 at University ED, with 2,836 samples collected during diversion device periods and 2,825 during standard equipment periods. Based on the ID physician review, the contaminant rates were 1.9% in diversion device periods versus 2.9% in standard equipment periods (P = 0.018). There was a marked difference in blood culture contamination rates between the two EDs with contaminant rates at the Memorial ED of 1.1% and 1.4% (P=0.57), and at the University ED of 2.3% and 3.5% (P=0.024) for the diversion device and standard equipment periods, respectively. CONCLUSION: The blood diversion device was able to significantly lower blood culture contamination rates overall by 1% at the institution’s two EDs (34% relative reduction), with a stronger effect noted at the campus with both a level 1 trauma center and transplant programs. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644678
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86446782021-12-06 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination Arnaout, Sami Ellison, Richard T Greenough, Thomas C Wedig, Azalea Mitchell, Michael J John, Lauren St Stock, Shannon Open Forum Infect Dis Oral Abstracts BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bottle. We have assessed the effectiveness of one blood diversion device in a prospective trial performed at the two separate emergency departments (EDs) of a three-campus Academic Medical Center. METHODS: A multi-phase prospective crossover trial was performed with the blood diversion device initially in use at one ED (Memorial) and standard equipment at the other ED (University) for 10 weeks. After a washout phase, a second 10-week study phase used the blood diversion device in the other ED (University) and standard equipment at the first ED (Memorial). Contaminants were identified by the clinical microbiology lab using standard criteria, and further defined by independent retrospective review by 3 infectious disease physicians prior to statistical analysis. An intention-to-treat analysis was performed, and Chi-square tests were used to compare contaminant rates among samples obtained using the blood diversion device versus standard equipment. RESULTS: 5,675 blood samples were obtained with 5,661 samples analyzed after 14 were deemed inconclusive by the ID physician review. There were 1,719 samples obtained at Memorial ED and 3,942 at University ED, with 2,836 samples collected during diversion device periods and 2,825 during standard equipment periods. Based on the ID physician review, the contaminant rates were 1.9% in diversion device periods versus 2.9% in standard equipment periods (P = 0.018). There was a marked difference in blood culture contamination rates between the two EDs with contaminant rates at the Memorial ED of 1.1% and 1.4% (P=0.57), and at the University ED of 2.3% and 3.5% (P=0.024) for the diversion device and standard equipment periods, respectively. CONCLUSION: The blood diversion device was able to significantly lower blood culture contamination rates overall by 1% at the institution’s two EDs (34% relative reduction), with a stronger effect noted at the campus with both a level 1 trauma center and transplant programs. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644678/ http://dx.doi.org/10.1093/ofid/ofab466.114 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Abstracts
Arnaout, Sami
Ellison, Richard T
Greenough, Thomas C
Wedig, Azalea
Mitchell, Michael J
John, Lauren St
Stock, Shannon
114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title_full 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title_fullStr 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title_full_unstemmed 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title_short 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
title_sort 114. prospective trial of passive diversion device to reduce blood culture contamination
topic Oral Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644678/
http://dx.doi.org/10.1093/ofid/ofab466.114
work_keys_str_mv AT arnaoutsami 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT ellisonrichardt 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT greenoughthomasc 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT wedigazalea 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT mitchellmichaelj 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT johnlaurenst 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination
AT stockshannon 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination